1.
Rituximab in the Treatment of Refractory Myasthenia Gravis: Studying the Outcomes Using MMT Score And Need for Plasmapheresis in Baghdad Teaching Hospital. Indian Journal of Forensic Medicine & Toxicology. 2020;14(2):2505-2510. doi:10.37506/ijfmt.v14i2.3485